Wyeth To See First Copies Of Tazocin In EU From Orchid Chemicals
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - U.S. drug maker Wyeth will see its first competition in Europe for key antibiotic drug Zosyn, or Tazocin, from Indian drug maker Orchid Chemicals. After almost a wait of more than a year, Orchid received approvals or Marketing Authorization for piperacillin/tazobactum injectibles in the EU countries
You may also be interested in...
U.S. Court Backs U.S. FDA Over Wyeth's Plea To Protect Zosyn From Orchid's Generic Copies
MUMBAI - In a blow to Wyeth in its attempts to protect anti-bacterial combination injection Zosyn (piperacillin/tazobactum), the U.S. District Court of Columbia dismised a plea for a temporary restraining order against the U.S. FDA's decision to approve generic copies of the drug from India's Orchid Chemicals
U.S. Court Backs U.S. FDA Over Wyeth's Plea To Protect Zosyn From Orchid's Generic Copies
MUMBAI - In a blow to Wyeth in its attempts to protect anti-bacterial combination injection Zosyn (piperacillin/tazobactum), the U.S. District Court of Columbia dismised a plea for a temporary restraining order against the U.S. FDA's decision to approve generic copies of the drug from India's Orchid Chemicals
Canada Clears Antibiotic Combo Of India’s Orchid
India's Orchid Chemicals and Pharmaceuticals got Canadian clearance to sell its combination piperacillin-tazobactam antibiotic. The Therapeutic Products Directorate allowed the combination of antibiotic injections for treating bacterial infections. Piperacilin is based on penicillin and tazobactam enhances its effectiveness. (Click here for more
Need a specific report? 1000+ reports available
Buy Reports